No increased overall risk of systemic events with use of anti-VEGF eye treatments
1. There was no overall increase in systemic cardiovascular events with the use of antibodies to vascular endothelial growth factor ...
Tag: bevacizumab
Becavizumab may improve progression free survival in platinum-resistant ovarian cancer
Image: PD 1. Combining bevacizumab with standard chemotherapy improved progression free survival and objective response rate in platinum-resistant ovarian cancer. ...
2 Minute Medicine Rewind February 17 – February 23, 2014
Image: PD In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the ...
First line bevacizumab fails to improve survival newly diagnosed glioblastoma patients [AVAglio trial]
Image: PD 1. Bevacizumab as a first-line agent alongside temozolomide and radiotherapy increased progression-free survival, but did not increase overall ...
![Addition of bevacizumab fails to benefit overall survival in newly diagnosed glioblastoma [RTOG 0825 trial]](https://www.2minutemedicine.com/wp-content/uploads/2014/02/AFIP-00405558-Glioblastoma-Radiology-e1381685577283-350x250.jpg)
Addition of bevacizumab fails to benefit overall survival in newly diagnosed glioblastoma [RTOG 0825 trial]
Image: PD 1. When added after initial treatment with temozolomide and radiotherapy, bevacizumab did not improve overall survival in newly ...